Loading…
Metabolic decompensation in pump users due to lispro insulin precipitation
Small, short term studies show that lispro insulin (Humalog; Eli Lilly & Co, Indianapolis, IN), commonly used in pump therapy, is stable in insulin pumps. 1 However, in agreement with reports by others, 2 we have noted several patients who have developed erratic and unpredictable glucose fluctua...
Saved in:
Published in: | BMJ 2002-05, Vol.324 (7348), p.1253-1253 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 1253 |
container_issue | 7348 |
container_start_page | 1253 |
container_title | BMJ |
container_volume | 324 |
creator | Wolpert, Howard A Faradji, Raquel N Bonner-Weir, Susan Lipes, Myra A |
description | Small, short term studies show that lispro insulin (Humalog; Eli Lilly & Co, Indianapolis, IN), commonly used in pump therapy, is stable in insulin pumps. 1 However, in agreement with reports by others, 2 we have noted several patients who have developed erratic and unpredictable glucose fluctuations with lispro insulin that have resolved when the treatment was changed to buffered regular insulin (Velosulin; Novo Nordisk, Princeton, NJ) and aspart insulin (Novolog; Novo Nordisk, Princeton, NJ). |
doi_str_mv | 10.1136/bmj.324.7348.1253 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_113278</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4006561541</sourcerecordid><originalsourceid>FETCH-LOGICAL-b421t-40faecb56f544048403167a48d33c4612325c369f56501160d426645fa2814b13</originalsourceid><addsrcrecordid>eNp1ks1u1DAUhS1ERUdtH4ANikB01Qy2r_-y6AKNSqEtsClsLcdxwEMSBztB8PY4zNACEitLvt85uj4-CD0meE0IiBd1v10DZWsJTK0J5fAArQgTquQK4CFa4YpXpSKgDtFJSluMMQWpKsEfoUNCMVWVwit09dZNpg6dt0XjbOhHNyQz-TAUfijGuR-LObmYimZ2xRSKzqcxhjxLc7cA0Vk_-umX4hgdtKZL7mR_HqEPry5uN6_Lm_eXbzYvb8qaUTKVDLfG2ZqLljOGmWIYiJCGqQbAMkEoUG5BVC0XHBMicMOoEIy3hirCagJH6HznO8517xrrhimaTo_R9yb-0MF4_fdk8J_1p_BN59ioVFl_utfH8HV2adK9T9Z1nRlcmJOWRGLJhMjg03_AbZjjkN-mKYYcn6LLNs_-BxEppViseKae_Lnz3bK_PyIDz_eASdZ0bTSD9emeYzkj4JC5csf5NLnvd3MTv-gMSK7ffdxoVV3fXlWY6uvMn-34XJd7N7xkIfRylyuklwrppULwE_cHs7Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777607465</pqid></control><display><type>article</type><title>Metabolic decompensation in pump users due to lispro insulin precipitation</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>JSTOR Archival Journals and Primary Sources Collection</source><source>BMJ Journals</source><creator>Wolpert, Howard A ; Faradji, Raquel N ; Bonner-Weir, Susan ; Lipes, Myra A</creator><creatorcontrib>Wolpert, Howard A ; Faradji, Raquel N ; Bonner-Weir, Susan ; Lipes, Myra A</creatorcontrib><description>Small, short term studies show that lispro insulin (Humalog; Eli Lilly & Co, Indianapolis, IN), commonly used in pump therapy, is stable in insulin pumps. 1 However, in agreement with reports by others, 2 we have noted several patients who have developed erratic and unpredictable glucose fluctuations with lispro insulin that have resolved when the treatment was changed to buffered regular insulin (Velosulin; Novo Nordisk, Princeton, NJ) and aspart insulin (Novolog; Novo Nordisk, Princeton, NJ).</description><edition>International edition</edition><identifier>ISSN: 0959-8138</identifier><identifier>ISSN: 0959-8146</identifier><identifier>EISSN: 1468-5833</identifier><identifier>EISSN: 1756-1833</identifier><identifier>DOI: 10.1136/bmj.324.7348.1253</identifier><identifier>PMID: 12028980</identifier><identifier>CODEN: BMJOAE</identifier><language>eng</language><publisher>London: British Medical Journal Publishing Group</publisher><subject>Adult ; Biological and medical sciences ; Case studies ; Catheters ; Chemical Precipitation ; Diabetes ; Diabetes Mellitus, Type 1 - drug therapy ; Female ; Glucose ; Hormones. Endocrine system ; Humans ; Hyperglycemia ; Hypoglycemia ; Hypoglycemic Agents - adverse effects ; Infusion Pumps, Implantable ; Insulin ; Insulin - adverse effects ; Insulin - analogs & derivatives ; Insulin Infusion Systems ; Insulin Lispro ; Medical sciences ; Metabolism ; Pharmacology. Drug treatments</subject><ispartof>BMJ, 2002-05, Vol.324 (7348), p.1253-1253</ispartof><rights>2002 BMJ Publishing Group Ltd.</rights><rights>2002 INIST-CNRS</rights><rights>Copyright: 2002 (c) 2002 BMJ Publishing Group Ltd.</rights><rights>Copyright BMJ Publishing Group May 25, 2002</rights><rights>Copyright © 2002, BMJ 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://bmj.com/content/324/7348/1253.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://bmj.com/content/324/7348/1253.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>112,113,230,314,780,784,885,27924,27925,30999,77594,77595</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14167353$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12028980$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wolpert, Howard A</creatorcontrib><creatorcontrib>Faradji, Raquel N</creatorcontrib><creatorcontrib>Bonner-Weir, Susan</creatorcontrib><creatorcontrib>Lipes, Myra A</creatorcontrib><title>Metabolic decompensation in pump users due to lispro insulin precipitation</title><title>BMJ</title><addtitle>BMJ</addtitle><description>Small, short term studies show that lispro insulin (Humalog; Eli Lilly & Co, Indianapolis, IN), commonly used in pump therapy, is stable in insulin pumps. 1 However, in agreement with reports by others, 2 we have noted several patients who have developed erratic and unpredictable glucose fluctuations with lispro insulin that have resolved when the treatment was changed to buffered regular insulin (Velosulin; Novo Nordisk, Princeton, NJ) and aspart insulin (Novolog; Novo Nordisk, Princeton, NJ).</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Case studies</subject><subject>Catheters</subject><subject>Chemical Precipitation</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 1 - drug therapy</subject><subject>Female</subject><subject>Glucose</subject><subject>Hormones. Endocrine system</subject><subject>Humans</subject><subject>Hyperglycemia</subject><subject>Hypoglycemia</subject><subject>Hypoglycemic Agents - adverse effects</subject><subject>Infusion Pumps, Implantable</subject><subject>Insulin</subject><subject>Insulin - adverse effects</subject><subject>Insulin - analogs & derivatives</subject><subject>Insulin Infusion Systems</subject><subject>Insulin Lispro</subject><subject>Medical sciences</subject><subject>Metabolism</subject><subject>Pharmacology. Drug treatments</subject><issn>0959-8138</issn><issn>0959-8146</issn><issn>1468-5833</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><recordid>eNp1ks1u1DAUhS1ERUdtH4ANikB01Qy2r_-y6AKNSqEtsClsLcdxwEMSBztB8PY4zNACEitLvt85uj4-CD0meE0IiBd1v10DZWsJTK0J5fAArQgTquQK4CFa4YpXpSKgDtFJSluMMQWpKsEfoUNCMVWVwit09dZNpg6dt0XjbOhHNyQz-TAUfijGuR-LObmYimZ2xRSKzqcxhjxLc7cA0Vk_-umX4hgdtKZL7mR_HqEPry5uN6_Lm_eXbzYvb8qaUTKVDLfG2ZqLljOGmWIYiJCGqQbAMkEoUG5BVC0XHBMicMOoEIy3hirCagJH6HznO8517xrrhimaTo_R9yb-0MF4_fdk8J_1p_BN59ioVFl_utfH8HV2adK9T9Z1nRlcmJOWRGLJhMjg03_AbZjjkN-mKYYcn6LLNs_-BxEppViseKae_Lnz3bK_PyIDz_eASdZ0bTSD9emeYzkj4JC5csf5NLnvd3MTv-gMSK7ffdxoVV3fXlWY6uvMn-34XJd7N7xkIfRylyuklwrppULwE_cHs7Q</recordid><startdate>20020525</startdate><enddate>20020525</enddate><creator>Wolpert, Howard A</creator><creator>Faradji, Raquel N</creator><creator>Bonner-Weir, Susan</creator><creator>Lipes, Myra A</creator><general>British Medical Journal Publishing Group</general><general>British Medical Association</general><general>BMJ Publishing Group LTD</general><general>BMJ Publishing Group</general><general>BMJ</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7QJ</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20020525</creationdate><title>Metabolic decompensation in pump users due to lispro insulin precipitation</title><author>Wolpert, Howard A ; Faradji, Raquel N ; Bonner-Weir, Susan ; Lipes, Myra A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b421t-40faecb56f544048403167a48d33c4612325c369f56501160d426645fa2814b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Case studies</topic><topic>Catheters</topic><topic>Chemical Precipitation</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 1 - drug therapy</topic><topic>Female</topic><topic>Glucose</topic><topic>Hormones. Endocrine system</topic><topic>Humans</topic><topic>Hyperglycemia</topic><topic>Hypoglycemia</topic><topic>Hypoglycemic Agents - adverse effects</topic><topic>Infusion Pumps, Implantable</topic><topic>Insulin</topic><topic>Insulin - adverse effects</topic><topic>Insulin - analogs & derivatives</topic><topic>Insulin Infusion Systems</topic><topic>Insulin Lispro</topic><topic>Medical sciences</topic><topic>Metabolism</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wolpert, Howard A</creatorcontrib><creatorcontrib>Faradji, Raquel N</creatorcontrib><creatorcontrib>Bonner-Weir, Susan</creatorcontrib><creatorcontrib>Lipes, Myra A</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library (ProQuest)</collection><collection>Science Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMJ</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wolpert, Howard A</au><au>Faradji, Raquel N</au><au>Bonner-Weir, Susan</au><au>Lipes, Myra A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolic decompensation in pump users due to lispro insulin precipitation</atitle><jtitle>BMJ</jtitle><addtitle>BMJ</addtitle><date>2002-05-25</date><risdate>2002</risdate><volume>324</volume><issue>7348</issue><spage>1253</spage><epage>1253</epage><pages>1253-1253</pages><issn>0959-8138</issn><issn>0959-8146</issn><eissn>1468-5833</eissn><eissn>1756-1833</eissn><coden>BMJOAE</coden><abstract>Small, short term studies show that lispro insulin (Humalog; Eli Lilly & Co, Indianapolis, IN), commonly used in pump therapy, is stable in insulin pumps. 1 However, in agreement with reports by others, 2 we have noted several patients who have developed erratic and unpredictable glucose fluctuations with lispro insulin that have resolved when the treatment was changed to buffered regular insulin (Velosulin; Novo Nordisk, Princeton, NJ) and aspart insulin (Novolog; Novo Nordisk, Princeton, NJ).</abstract><cop>London</cop><pub>British Medical Journal Publishing Group</pub><pmid>12028980</pmid><doi>10.1136/bmj.324.7348.1253</doi><tpages>1</tpages><edition>International edition</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0959-8138 |
ispartof | BMJ, 2002-05, Vol.324 (7348), p.1253-1253 |
issn | 0959-8138 0959-8146 1468-5833 1756-1833 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_113278 |
source | Applied Social Sciences Index & Abstracts (ASSIA); JSTOR Archival Journals and Primary Sources Collection; BMJ Journals |
subjects | Adult Biological and medical sciences Case studies Catheters Chemical Precipitation Diabetes Diabetes Mellitus, Type 1 - drug therapy Female Glucose Hormones. Endocrine system Humans Hyperglycemia Hypoglycemia Hypoglycemic Agents - adverse effects Infusion Pumps, Implantable Insulin Insulin - adverse effects Insulin - analogs & derivatives Insulin Infusion Systems Insulin Lispro Medical sciences Metabolism Pharmacology. Drug treatments |
title | Metabolic decompensation in pump users due to lispro insulin precipitation |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T15%3A34%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolic%20decompensation%20in%20pump%20users%20due%20to%20lispro%20insulin%20precipitation&rft.jtitle=BMJ&rft.au=Wolpert,%20Howard%20A&rft.date=2002-05-25&rft.volume=324&rft.issue=7348&rft.spage=1253&rft.epage=1253&rft.pages=1253-1253&rft.issn=0959-8138&rft.eissn=1468-5833&rft.coden=BMJOAE&rft_id=info:doi/10.1136/bmj.324.7348.1253&rft_dat=%3Cproquest_pubme%3E4006561541%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b421t-40faecb56f544048403167a48d33c4612325c369f56501160d426645fa2814b13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1777607465&rft_id=info:pmid/12028980&rfr_iscdi=true |